Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Preclinical Imaging (In-VIVO) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Preclinical Imaging (In-VIVO)market, defines the market attractiveness level of Preclinical Imaging (In-VIVO) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Preclinical Imaging (In-VIVO) industry, describes the types of Preclinical Imaging (In-VIVO) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Preclinical Imaging (In-VIVO) market and the development prospects and opportunities of Preclinical Imaging (In-VIVO) industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Preclinical Imaging (In-VIVO) market in Chapter 13.
By Player:
Bruker Corporation
PerkinElmer
MR Solutions
LI-COR Biosciences
Miltenyi Biotec
Aspect Imaging
Mediso
MILabs BV
Trifoil Imaging
FUJIFILM Holdings
By Type:
Modality
Reagent
Others
By End-User:
Oncology
Cardio and Vascular
Neurology
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Preclinical Imaging (In-VIVO) Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Preclinical Imaging (In-VIVO) Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Preclinical Imaging (In-VIVO) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Preclinical Imaging (In-VIVO) Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Preclinical Imaging (In-VIVO) Market Analysis and Outlook to 2022
-
7.1 Global Preclinical Imaging (In-VIVO) Consumption (2017-2022)
-
7.2 United States Preclinical Imaging (In-VIVO) Consumption (2017-2022)
-
7.3 Europe Preclinical Imaging (In-VIVO) Consumption (2017-2022)
-
7.4 China Preclinical Imaging (In-VIVO) Consumption (2017-2022)
-
7.5 Japan Preclinical Imaging (In-VIVO) Consumption (2017-2022)
-
7.6 India Preclinical Imaging (In-VIVO) Consumption (2017-2022)
-
7.7 South Korea Preclinical Imaging (In-VIVO) Consumption (2017-2022)
8 Region and Country-wise Preclinical Imaging (In-VIVO) Market Analysis and Outlook to 2028
-
8.1 Global Preclinical Imaging (In-VIVO) Consumption Forecast (2022-2028)
-
8.2 United States Preclinical Imaging (In-VIVO) Consumption Forecast (2022-2028)
-
8.3 Europe Preclinical Imaging (In-VIVO) Consumption Forecast (2022-2028)
-
8.4 China Preclinical Imaging (In-VIVO) Consumption Forecast (2022-2028)
-
8.5 Japan Preclinical Imaging (In-VIVO) Consumption Forecast (2022-2028)
-
8.6 India Preclinical Imaging (In-VIVO) Consumption Forecast (2022-2028)
-
8.7 South Korea Preclinical Imaging (In-VIVO) Consumption Forecast (2022-2028)
9 Global Preclinical Imaging (In-VIVO) Market Outlook by Types and Applications to 2022
-
9.1 Global Preclinical Imaging (In-VIVO) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Modality Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Reagent Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Preclinical Imaging (In-VIVO) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardio and Vascular Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Neurology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Preclinical Imaging (In-VIVO) Market Outlook by Types and Applications to 2028
-
10.1 Global Preclinical Imaging (In-VIVO) Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Modality Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Reagent Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Preclinical Imaging (In-VIVO) Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cardio and Vascular Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Neurology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Preclinical Imaging (In-VIVO) Import and Export Analysis (Top 5 Countries)
-
11.1 Global Preclinical Imaging (In-VIVO) Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Preclinical Imaging (In-VIVO) Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Preclinical Imaging (In-VIVO) Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Preclinical Imaging (In-VIVO) Market Competitive Analysis
-
14.1 Bruker Corporation
-
14.1.1 Bruker Corporation Company Details
-
14.1.2 Bruker Corporation Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bruker Corporation Preclinical Imaging (In-VIVO) Product and Service
-
14.2 PerkinElmer
-
14.2.1 PerkinElmer Company Details
-
14.2.2 PerkinElmer Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 PerkinElmer Preclinical Imaging (In-VIVO) Product and Service
-
14.3 MR Solutions
-
14.3.1 MR Solutions Company Details
-
14.3.2 MR Solutions Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 MR Solutions Preclinical Imaging (In-VIVO) Product and Service
-
14.4 LI-COR Biosciences
-
14.4.1 LI-COR Biosciences Company Details
-
14.4.2 LI-COR Biosciences Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 LI-COR Biosciences Preclinical Imaging (In-VIVO) Product and Service
-
14.5 Miltenyi Biotec
-
14.5.1 Miltenyi Biotec Company Details
-
14.5.2 Miltenyi Biotec Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Miltenyi Biotec Preclinical Imaging (In-VIVO) Product and Service
-
14.6 Aspect Imaging
-
14.6.1 Aspect Imaging Company Details
-
14.6.2 Aspect Imaging Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Aspect Imaging Preclinical Imaging (In-VIVO) Product and Service
-
14.7 Mediso
-
14.7.1 Mediso Company Details
-
14.7.2 Mediso Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Mediso Preclinical Imaging (In-VIVO) Product and Service
-
14.8 MILabs BV
-
14.8.1 MILabs BV Company Details
-
14.8.2 MILabs BV Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 MILabs BV Preclinical Imaging (In-VIVO) Product and Service
-
14.9 Trifoil Imaging
-
14.9.1 Trifoil Imaging Company Details
-
14.9.2 Trifoil Imaging Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Trifoil Imaging Preclinical Imaging (In-VIVO) Product and Service
-
14.10 FUJIFILM Holdings
-
14.10.1 FUJIFILM Holdings Company Details
-
14.10.2 FUJIFILM Holdings Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 FUJIFILM Holdings Preclinical Imaging (In-VIVO) Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Preclinical Imaging (In-VIVO)
-
Figure Preclinical Imaging (In-VIVO) Picture
-
Table Global Preclinical Imaging (In-VIVO) Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Preclinical Imaging (In-VIVO) Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Preclinical Imaging (In-VIVO) Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Preclinical Imaging (In-VIVO) Consumption by Country (2017-2022)
-
Figure United States Preclinical Imaging (In-VIVO) Consumption and Growth Rate (2017-2022)
-
Table Europe Preclinical Imaging (In-VIVO) Consumption and Growth Rate (2017-2022)
-
Figure China Preclinical Imaging (In-VIVO) Consumption and Growth Rate (2017-2022)
-
Figure Japan Preclinical Imaging (In-VIVO) Consumption and Growth Rate (2017-2022)
-
Figure India Preclinical Imaging (In-VIVO) Consumption and Growth Rate (2017-2022)
-
Figure South Korea Preclinical Imaging (In-VIVO) Consumption and Growth Rate (2017-2022)
-
Figure Global Preclinical Imaging (In-VIVO) Consumption Forecast by Country (2022-2028)
-
Figure United States Preclinical Imaging (In-VIVO) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Preclinical Imaging (In-VIVO) Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Preclinical Imaging (In-VIVO) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Preclinical Imaging (In-VIVO) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Preclinical Imaging (In-VIVO) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Preclinical Imaging (In-VIVO) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Modality Consumption and Growth Rate (2017-2022)
-
Figure Global Reagent Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Cardio and Vascular Consumption and Growth Rate (2017-2022)
-
Figure Global Neurology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Modality Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Reagent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardio and Vascular Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Preclinical Imaging (In-VIVO) Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Preclinical Imaging (In-VIVO) Export by Region (Top 5 Countries) (2017-2028)
-
Table Bruker Corporation (Foundation Year, Company Profile and etc.)
-
Table Bruker Corporation Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bruker Corporation Preclinical Imaging (In-VIVO) Product and Service
-
Table PerkinElmer (Foundation Year, Company Profile and etc.)
-
Table PerkinElmer Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
Table PerkinElmer Preclinical Imaging (In-VIVO) Product and Service
-
Table MR Solutions (Foundation Year, Company Profile and etc.)
-
Table MR Solutions Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
Table MR Solutions Preclinical Imaging (In-VIVO) Product and Service
-
Table LI-COR Biosciences (Foundation Year, Company Profile and etc.)
-
Table LI-COR Biosciences Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
Table LI-COR Biosciences Preclinical Imaging (In-VIVO) Product and Service
-
Table Miltenyi Biotec (Foundation Year, Company Profile and etc.)
-
Table Miltenyi Biotec Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Miltenyi Biotec Preclinical Imaging (In-VIVO) Product and Service
-
Table Aspect Imaging (Foundation Year, Company Profile and etc.)
-
Table Aspect Imaging Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aspect Imaging Preclinical Imaging (In-VIVO) Product and Service
-
Table Mediso (Foundation Year, Company Profile and etc.)
-
Table Mediso Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mediso Preclinical Imaging (In-VIVO) Product and Service
-
Table MILabs BV (Foundation Year, Company Profile and etc.)
-
Table MILabs BV Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
Table MILabs BV Preclinical Imaging (In-VIVO) Product and Service
-
Table Trifoil Imaging (Foundation Year, Company Profile and etc.)
-
Table Trifoil Imaging Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Trifoil Imaging Preclinical Imaging (In-VIVO) Product and Service
-
Table FUJIFILM Holdings (Foundation Year, Company Profile and etc.)
-
Table FUJIFILM Holdings Preclinical Imaging (In-VIVO) Sales, Price, Value and Gross Profit (2017-2022)
-
Table FUJIFILM Holdings Preclinical Imaging (In-VIVO) Product and Service
-
